Citation: R. Kondo et al., USE OF SV40 TO IMMUNIZE AGAINST HEPATITIS-B SURFACE-ANTIGEN - IMPLICATIONS FOR THE USE OF SV40 FOR GENE TRANSDUCTION AND ITS USE AS AN IMMUNIZING AGENT, Gene therapy, 5(5), 1998, pp. 575-582
Authors:
SUN BS
ZHU XH
CLAYTON MM
PAN JB
FEITELSON MA
Citation: Bs. Sun et al., IDENTIFICATION OF A PROTEIN ISOLATED FROM SENESCENT HUMAN-CELLS THAT BINDS TO HEPATITIS-B VIRUS-X ANTIGEN, Hepatology, 27(1), 1998, pp. 228-239
Authors:
WANG LY
CHEN CJ
ZHANG YJ
TSAI WY
LEE PH
FEITELSON MA
LEE CS
SANTELLA RM
Citation: Ly. Wang et al., 4-AMINOBIPHENYL DNA-DAMAGE IN LIVER-TISSUE OF HEPATOCELLULAR-CARCINOMA PATIENTS AND CONTROLS, American journal of epidemiology, 147(3), 1998, pp. 315-323
Citation: Pn. Ranganathan et Ma. Feitelson, DIRECT SYNTHESIS OF FULL-LENGTH P53 CDNA FROM FROZEN LIVER, Biochemistry and molecular biology international, 41(5), 1997, pp. 861-867
Authors:
FEITELSON MA
RANGANATHAN PN
CLAYTON MM
ZHANG SM
Citation: Ma. Feitelson et al., PARTIAL CHARACTERIZATION OF THE WOODCHUCK TUMOR-SUPPRESSOR, P53, AND ITS INTERACTION WITH WOODCHUCK HEPATITIS-VIRUS-X ANTIGEN IN HEPATOCARCINOGENESIS, Oncogene, 15(3), 1997, pp. 327-336
Citation: Hwl. Hann et al., ANTI-POL AND HBXAG MARKERS IN THE SERA OF PATIENTS WITH PRIMARY HEPATOCELLULAR-CARCINOMA (HCC), Hepatology, 26(4), 1997, pp. 459-459
Authors:
GREENBLATT MS
FEITELSON MA
ZHU M
BENNETT WP
WELSH JA
JONES R
BORKOWSKI A
HARRIS CC
Citation: Ms. Greenblatt et al., INTEGRITY OF P53 IN HEPATITIS-B X-ANTIGEN-POSITIVE AND X-ANTIGEN-NEGATIVE HEPATOCELLULAR CARCINOMAS, Cancer research, 57(3), 1997, pp. 426-432
Citation: Ma. Feitelson et Lx. Duan, HEPATITIS-B-VIRUS-X ANTIGEN IN THE PATHOGENESIS OF CHRONIC INFECTIONSAND THE DEVELOPMENT OF HEPATOCELLULAR-CARCINOMA, The American journal of pathology, 150(4), 1997, pp. 1141-1157
Authors:
HANN HWL
LI LL
FEITELSON MA
CLAYTON MM
MENDUKE H
Citation: Hwl. Hann et al., IRON DEPLETION - A POTENTIAL ANTICANCER THERAPY FOR HUMAN HEPATOCELLULAR-CARCINOMA (AN ANIMAL STUDY), Hepatology, 24(4), 1996, pp. 891-891
Citation: Hwl. Hann et al., HBXAG ANTI-HBX AND ANTI-POL MARKERS OF HEPATITIS-B VIRUS AS A GUIDE TO INTERFERON THERAPY FOR CHRONIC HEPATITIS/, Hepatology, 24(4), 1996, pp. 1577-1577
Citation: Ma. Feitelson et al., EVIDENCE FOR UNDERLYING HEPATITIS-B VIRUS-INFECTION AMONG MULTIPLY TRANSFUSED PATIENTS WITH SICKLE-CELL-ANEMIA, Blood, 88(10), 1996, pp. 2097-2097
Authors:
FEITELSON MA
DUAN LX
GUO J
HORIIKE N
MCINTYRE G
BLUMBERG BS
THOMAS HC
CARMAN W
Citation: Ma. Feitelson et al., PRECORE AND X-REGION MUTANTS IN HEPATITIS-B VIRUS-INFECTIONS AMONG RENAL DIALYSIS PATIENTS, Journal of viral hepatitis, 2(1), 1995, pp. 19-31
Authors:
FEITELSON MA
DUAN LX
GUO J
SUN B
WOO J
STEENSMA K
HORIIKE N
BLUMBERG BS
Citation: Ma. Feitelson et al., X-REGION DELETION VARIANTS OF HEPATITIS-B VIRUS IN SURFACE ANTIGEN-NEGATIVE INFECTIONS AND NON-A, NON-B-HEPATITIS, The Journal of infectious diseases, 172(3), 1995, pp. 713-722
Authors:
WANG XW
FORRESTER K
YEH H
FEITELSON MA
GU JR
HARRIS CC
Citation: Xw. Wang et al., HEPATITIS-B-VIRUS-X PROTEIN INHIBITS P53 SEQUENCE-SPECIFIC DNA-BINDING, TRANSCRIPTIONAL ACTIVITY, AND ASSOCIATION WITH TRANSCRIPTION FACTORERCC3, Proceedings of the National Academy of Sciences of the United Statesof America, 91(6), 1994, pp. 2230-2234